By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

New Guideline Provides Treatment Recommendations for Restless ... 31, 2024 — Sleep apnea, a common yet underdiagnosed sleep disorder, contributes to the development of dementia among adults ...

Winter brings less daylight and colder temperatures, which can disrupt sleep. Seasonal Affective Disorder (SAD) is more ...

In today’s fast-paced world, where stress and fatigue are commonplace, finding effective ways to enhance our well-being has ...

If it suddenly feels like you’re sleeping or feeling groggy more than you’re awake, you may be sleeping too much—also known ...

If you have been suffering from chronic pain and sleep disorders, a professional can guide you towards implementing a proper ...

Misdiagnosis happens in youngsters as it’s easy to dismiss symptoms as mood swings or work-induced stress, says psychiatrist ...

The agency’s decision expands the use of Zepbound and could potentially pave the way for Eli Lilly to gain broader insurance ...

The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...

The FDA has cleared Eli Lilly’s obesity drug Zepbound as the first treatment for obstructive sleep apnea in the U.S.

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...